Genistein protects the kidney from cisplatin-induced injury

Kidney Int. 2008 Dec;74(12):1538-47. doi: 10.1038/ki.2008.409. Epub 2008 Aug 20.

Abstract

Oxidative stress and inflammation contribute to the pathogenesis of cisplatin-induced nephrotoxicity. We found that genistein, a tyrosine kinase inhibitor with broad specificities, and which also has estrogen-like activity, had protective effects on cisplatin-induced renal injury in mice. Genistein significantly decreased reactive oxygen species production, the expression of intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 proteins, as well as the translocation of the p65 subunit of nuclear factor-kappaB into the nucleus and the infiltration of macrophages, all of which were increased in the kidney by cisplatin treatment. Genistein also decreased cisplatin-induced apoptosis by regulating p53 induction in kidney. Genistein significantly reduced reactive oxygen species production in cisplatin-treated normal human kidney HK-2 cells. These studies show that genistein or similar compounds might be useful in prevention of cisplatin-induced renal injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Adhesion Molecules / analysis
  • Cell Line
  • Cisplatin / adverse effects*
  • Genistein / pharmacology
  • Genistein / therapeutic use*
  • Humans
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / prevention & control*
  • Mice
  • Reactive Oxygen Species / analysis
  • Transcription Factor RelA / metabolism

Substances

  • Cell Adhesion Molecules
  • Reactive Oxygen Species
  • Transcription Factor RelA
  • Genistein
  • Cisplatin